TP53 wt Allele Recruiting Phase 1 / 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0082200 (TP53 wt Allele)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03634228Milademetan Tosylate and Low-Dose Cytarabine in Treating Participants With Recurrent or Refractory Acute Myeloid LeukemiaTreatment